For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230404:nRSD2314Va&default-theme=true
RNS Number : 2314V ADVFN PLC 04 April 2023
For immediate release
4 April 2023
ADVFN plc
("ADVFN" or the ''Company'')
Further equity issue
The Board of ADVFN announces that the Company has today conditionally issued
456 new Ordinary Shares pursuant to the exercise of 456 Open Offer Warrants at
an exercise price of 60 pence per new Ordinary Share. The proceeds from the
exercise amount to £274 and will be used for general working capital.
Application is being made to the London Stock Exchange for 456 new Ordinary
Shares to be admitted to trading on AIM and it is expected that Admission will
become effective and dealings will commence in the new Ordinary Shares at 8.00
a.m. on or around 11 April 2023. The new Ordinary Shares shall rank pari passu
in all respects with all other Ordinary Shares then in issue.
Following Admission, the Company will have 46,005,213 Ordinary Shares in issue
and admitted to trading on AIM.
A copy of this announcement is available on the Company's website,
www.advfnplc.com.
For further information please contact:
ADVFN plc +44 (0) 203 8794 460
Amit Tauman (CEO)
Beaumont Cornish Limited (Nominated Adviser) +44 (0) 207 628 3396
Michael Cornish
Roland Cornish
Peterhouse Capital Limited (Broker) +44 (0) 207 469 0930
Eran Zucker / Lucy Williams / Rose Greensmith
The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the
European Union (Withdrawal) Act 2018. The person who arranged for the release
of this announcement on behalf of the Company was Amit Tauman, Director.
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEFLFVTSSIVIIV